HPV infection and p16 expression in carcinomas of the minor salivary glands

European Archives of Oto-Rhino-Laryngology

Volumn 269, Issue 10, 2012, Pages 2265-2269

  Brunner, Markus ^a   Koperek, Oskar ^a   Wrba, Fritz ^a   Erovic, Boban M ^a   Heiduschka, Gregor ^a   Schoppper, Christian ^a   Thurnher, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

HPV; Minor salivary gland cancer; P16

Indexed keywords

PROTEIN VP16; VIRUS DNA;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LOW RISK POPULATION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; UPREGULATION;

ADENOCARCINOMA; ALPHAPAPILLOMAVIRUS; CARCINOMA, MUCOEPIDERMOID; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMAVIRUS INFECTIONS; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS, MINOR; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84867249535     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1894-2     Document Type: Article

References (23)

1. Conway MJ, Meyers C (2009) Replication and assembly of human papilloma viruses. J Dent Res 88:307-317
2. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5:e1000318
3. Rolfe M, Beer-Romero P, Glass S et al (1995) Reconstitution of p53-ubiquitinylation reactions from purified components: The role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). Proc Natl Acad Sci USA 92:3264-3268
4. Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82
5. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88
6. Merkley MA, Hildebrandt E, Podolsky RH et al (2009) Largescale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes. Proteome Sci 7:29
7. Smeets SJ, Hesselink AT, Speel EJ et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121:2465-2472
8. O'Regan EM, Toner ME, Finn SP et al (2008) p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 39: 452-458
9. Hoffmann M, Ihloff AS, Gorogh T et al (2010) p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 127:1595-1602
10. Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35
11. Allen CT, Lewis JS, El-Mofty SK, Haughey BH, Nussenbaum B (2010) Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications. Laryngoscope 120:1756-1772
12. Speight P, Barrett A (2002) Salivary gland tumours. Oral Dis 8:229-240
13. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. In: World Health Organization classification of tumors, IARC Press, Lyon
14. Vageli D, Sourvinos G, Ioannou M, Koukoulis GK, Spandidos DA (2007) High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers 22:239-244
15. Atula T, Grénman R, Klemi P, Syrjanen S (1998) Human papillomavirus, Epstein-Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncol 34:391-395
16. Guo XL, Sun SZ, Wang WX, Wei FC, Yu HB, Ma BL (2007) Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands. Int J Oral Maxillofac Surg 36:350-353
17. Vékony H, Roser K, Loning T et al (2008) Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands. Histopathology 53:658-666
18. Birner P, Bachtiary B, Dreier B et al (2001) Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol 14:702-709
19. Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Loning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma: A report of 50 cases. Cancer 103:2526-2533
20. Etges A, Nunes FD, Ribeiro KC, Araújo VC (2004) Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol 40:326-331
21. Schlecht NF, Brandwein-Gensler M, Nuovo GJ et al. (2011) A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol [Epub ahead of print]
22. O'Neill CJ, McCluggage WG (2006) p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 13:8-15
23. Houghton O, Jamison J, Wilson R, Carson J, McCluggage WG (2010) p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology 57:342-350